strataskinsciences.com (SSKN) - Long-Term Debt to Capital Coefficient

Corporate emblem and logo of STRATA Skin Sciences Inc. (SSKN)

STRATA Skin Sciences (SSKN) maintains its position in the laser skin treatment niche through unique patents for XTRAC systems, offering an alternative to topical ointments for vitiligo. Stable demand in dermatology is supported by the sale of components and paid sessions. This price chart with the 10.43 indicator reflects the dynamics of the asset, whose production is localized in the US and relies on a network of partner clinics.

SSKN strataskinsciences.com: Long-Term Debt to Equity in the range 07/04/2022 - 02/21/2026

Analytical breakdowns for STRATA Skin Sciences

- share price and consensus valuation forecast:
Price STRATA Skin|SSKN - Analyst Consensus Forecast
- market capitalization indicators:
Market Value STRATA Skin Sciences, Inc.|SSKN - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share STRATA Skin Sciences|SSKN - Company Book Value|Market Value to Book Value strataskinsciences.com|SSKN - Company Total Assets
- debt and solvency information:
Total Debt to Capital STRATA Skin Sciences|SSKN - Long-Term Debt to Equity|Current Liabilities to Equity STRATA Skin|SSKN - Company Aggregate Debts|Debts to Book Value STRATA Skin Sciences, Inc.|SSKN - Company Long-Term Liabilities|Company Short-Term Debts STRATA Skin Sciences|Intermediate Liquidity Ratio strataskinsciences.com
- business earnings and investment ratios data:
SSKN - Net Profit
Summary company analysis:SSKN (strataskinsciences.com)
Core merchandise of STRATA Skin Sciences Inc.

Long-term investments require strict control over the capital structure's resilience to external shocks. For the owner of the XTRAC ecosystem, STRATA Skin Sciences (SSKN) must critically balance borrowed funds with the scaling of unique dermatological solutions. The long-term debt-to-equity ratio reflects the proportion of liabilities exceeding one year relative to shareholder equity. A decline in this curve signals deleveraging and increased financial autonomy. An optimal balance minimizes default risks while preserving expansion potential.

Competing companies

DXCM (DexCom Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital PEN|NOVT (Novanta Photonics) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Long-Term Liabilities to Capital|PRCT - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient CNMD (CONMED Corp)|PLSE: Long-Term Debt to Capital|InMode MD (INMD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc|surmodics.com - Long-Term Liabilities to Equity|Long-Term Debt to Capital SENS|NPCE - Long-Term Liabilities to Capital|Tactile Medical - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital SANUWAVE Health Inc SNWV|OM: Long-Term Debt to Equity Ratio|Electromed, Inc. - Long-Term Loans to Capital Ratio|LNSR: Long-Term Debt to Capital|RCEL - Ratio of Long-Term Indebtedness to Capital|PROF (Profound Medical Corp) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|Long-Term Debt to Equity Ratio EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity IceCure Medical ICCM|LUNG - Long-Term Debt to Equity Ratio|TELA Bio Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Cytosorbents|SRTS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ZYXI|ECOR (electroCore Inc) - Long-Term Debt to Capital|Vicarious Surgical Corp (RBOT) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital IINN|Long-Term Debt to Equity Ratio SeaStar Medical Holding Corp. ICU|Long-Term Debt to Capital IRIX (IRIDEX)|Long-Term Debt to Capital Intelligent Bio Solutions Inc INBS|XAIR - Long-Term Debt to Equity|PFSA: Long-Term Debt to Equity|GCTK (GlucoTrack) - Long-Term Debt to Equity Ratio|NanoVibronix Inc. - Long-Term Debt to Capital Coefficient|VERO (Venus Concept Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital nuwellis.com NUWE|Long-Term Debt to Equity Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Long-Term Indebtedness to Equity|Avinger, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Cutera, Inc. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital knowlabs.co KNW|Inari Medical (NARI) - Long-Term Debt to Equity|Long-Term Liabilities to Equity NVRO (Nevro Corp)|Long-Term Debt to Equity ReShape Lifesciences, Inc.|Long-Term Debt to Equity Ratio Silk Road Medical Inc (SILK)